Tuesday, March 31, 2020

BRIEF-Immunoprecise's Artificial Intelligence Partner, EVQLV, Submits First Panel Of Optimized Antibody Sequences To Coronavirus For Polytope Mab Therapy Program - Reuters

BRIEF-Immunoprecise's Artificial Intelligence Partner, EVQLV, Submits First Panel Of Optimized Antibody Sequences To Coronavirus For Polytope Mab Therapy Program  Reuters